Literature DB >> 17062765

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

Laura Pellatt1, Laurine Hanna, Mark Brincat, Ray Galea, Henrietta Brain, Saffron Whitehead, Helen Mason.   

Abstract

CONTEXT: There has been renewed interest in anti-Müllerian hormone (AMH) because of its role in the ovary. Data on its actions are sparse, but it appears to inhibit follicle growth. Interestingly, serum AMH is two to three times higher in women with polycystic ovary (PCO) syndrome than women with normal ovaries.
OBJECTIVE: We examined the production of AMH by cells from a range of follicle sizes from normal ovaries and compared this with production by ovulatory and anovulatory (anov) PCOs.
DESIGN: Granulosa cells (GCs) and theca and follicular fluid (ff) were isolated from intact follicles. Cells were cultured for 48 h +/- FSH or LH, and AMH was measured in ff and cell-conditioned media (CM).
RESULTS: AMH levels in ff and GC-CM ranged from 42 to 2240 and 0.025 to 1.7 ng/ml, respectively, and were low or undetectable in ff and GC-CM from follicles greater than 9 mm, luteinized cells, and theca and stroma. The mean level of AMH was four times higher in GC-CM from ovulatory PCOs [mean (range) 1.56 (0.025-7)] and 75 times higher from anovPCO [21.4 (17.2-43 ng/ml)] than normal ovaries [0.37 (0.025-1.7)]. Neither LH nor FSH had an effect on AMH production by GCs from normal ovaries, but in cells from PCOs, FSH significantly decreased AMH, and in contrast, LH increased AMH.
CONCLUSIONS: The reduction of AMH in follicles greater than 9 mm from normal ovaries appears to be an important requirement for the selection of the dominant follicle. AMH production per GC was 75 times higher in anovPCOs, compared with normal ovaries. This increase in AMH may contribute to failure of follicle growth and ovulation seen in polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062765     DOI: 10.1210/jc.2006-1582

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  108 in total

1.  Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.

Authors:  Soledad Henríquez; Paulina Kohen; Xia Xu; Claudio Villarroel; Alex Muñoz; Ana Godoy; Jerome F Strauss; Luigi Devoto
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

2.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

3.  17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome.

Authors:  Jingwen Hou; Heidi Cook-Andersen; H Irene Su; Rana Shayya; Kevin H Maas; Christine M Burt-Solorzano; Ajay Kumar; R Jeffrey Chang
Journal:  J Pediatr Endocrinol Metab       Date:  2016-07-01       Impact factor: 1.634

4.  Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome.

Authors:  P Saikumar; Vs Kalai Selvi; K Prabhu; Prasana Venkatesh; Prashanth Krishna
Journal:  J Clin Diagn Res       Date:  2013-09-10

5.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

6.  FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH.

Authors:  Zhilin Liu; Diego H Castrillon; Wei Zhou; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2013-01-15

7.  Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.

Authors:  Melissa Pawelczak; Lisa Kenigsberg; Sarah Milla; Ying-Hua Liu; Bina Shah
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

8.  Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.

Authors:  Peter J Malloy; Lihong Peng; Jining Wang; David Feldman
Journal:  Endocrinology       Date:  2008-12-04       Impact factor: 4.736

9.  Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Authors:  Daniel A Dumesic; Timothy G Lesnick; Jacques P Stassart; G David Ball; Ashley Wong; David H Abbott
Journal:  Fertil Steril       Date:  2009-07       Impact factor: 7.329

10.  An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats.

Authors:  Natalia R Salvetti; Carolina G Panzani; Eduardo J Gimeno; Leandro G Neme; Natalia S Alfaro; Hugo H Ortega
Journal:  Reprod Biol Endocrinol       Date:  2009-07-01       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.